Objective: Readmission rates are expected to have an increasing effect on both the hospital bottom line and physician reimbursements. Safety net hospitals may be most vulnerable. We examined readmissions at 30 days, 90 days, and 1 year in a large safety net hospital to determine the magnitude and effect of short-and long-term readmission rates after lower extremity infrainguinal bypass in this setting.
Cost containment and value based healthcare have been the focus of the United States' evolving healthcare system. 1 Accountable Care Organizations and other similar models are organized so that the hospitals assume the total costs of patient care and are reimbursed a fixed amount. 2, 3 It is unclear how this will affect hospital systems, and in particular safety net hospitals, which currently take care of a higher percentage of uninsured and underinsured patients. 4, 5 Patients in these hospitals tend to have fewer resources and social support and, as such, these institutions may be at risk for being disproportionately penalized, because they have been historically shown to have higher perioperative readmission rates. [4] [5] [6] Early postoperative readmissions have been highlighted as a source of intensive healthcare spending and are a possible target for cost savings. 6, 7 Specifically, vascular surgery patients are known to have high postoperative readmission rates, regardless of the procedure.
This circumstance is particularly true for patients undergoing lower extremity infrainguinal bypass (LEB). [10] [11] [12] [13] [14] [15] Readmission data identified in previous studies only considered postoperative readmission at 30 days and have been high, ranging from 14% to 24%. [10] [11] [12] [13] [14] [15] These data have based either on multi-institutional database analyses or from nonesafety net hospitals. There has been no detailed analysis of readmissions beyond the 30-day period. Evaluation of readmissions at 90 days and 1 year is important because such data may have implications for both the surgery global period and the Accountable Care Organization shared risk model. As healthcare approaches a new model of shared risks, it is important to establish baseline readmission details for high-risk populations. Therefore, we assessed the 30-day, 90-day, and 1-year readmission rates after LEB surgery at the largest safety net hospital in New England.
METHODS
A retrospective chart review was conducted of all patients who underwent LEB at Boston Medical Center between 2008 and 2016. All emergent cases were excluded, because many of these cases involve trauma and multiple other injuries. The Boston University School of Medicine Institutional Review Board approved this study and patient consent was waived. Bypass details, patient demographics, and comorbidities were recorded. Indications were classified as claudication, rest pain, and tissue loss. Patient characteristics considered in the analysis included age, gender, race, and insurance status. Patient comorbidities included ambulatory status (defined as the need of a walking aid or being nonambulatory), obesity defined as a body mass index of $30 kg/m 2 , current smoking status, diabetes, hypertension, coronary artery disease, congestive heart failure (CHF), chronic obstructive pulmonary disease, dialysis use, dementia, prior stroke, and liver failure. Procedural details including bypass origin, target, and conduit type were also analyzed. In-hospital and 30-day complications, including surgical wound complications, urinary tract infection, myocardial infarction, bleeding, pulmonary complications, stroke, renal failure, and graft occlusion were recorded. The main outcomes measured in the study were the 30-day, 90-day, and 1-year patient readmission rates. Readmission was defined as any inpatient status within that time period. We do not routinely have planned readmissions after bypass and often performed foot surgery at the time of the index admission. Readmissions were further subclassified by the cause for readmission. Reasons for readmission were divided into surgical wound complications (including superficial and deep surgical site infection and wound dehiscence), nonsurgical foot/ leg wounds (ischemic ulcers and tissue loss), nonextremity infections, cardiac ischemia, stroke, CHF, ipsilateral leg pain, contralateral leg morbidity, unrelated operations, renal failure, diabetic complications, graft complications, altered mental status, gastrointestinal, anemia, acute limb ischemia, and other. Our service generally works in multidisciplinary effort in conjunction with podiatry, cardiology, physical therapy, infectious disease, and endocrinology specialist to treat our patients. Minor amputations are generally performed by the podiatry service.
Patient and procedural factors were described with counts and percentages. For each factor level, counts and percentages of readmission were reported. Logistic regression models were used to evaluate the association between each individual factor and 30-day, 90-day, and 1-year readmission. All factors significantly (at very liberal 0.5 level) associated with readmission in unadjusted analyses were then entered into multivariable logistic regressions for each outcome. Backward elimination procedure with an 0.2 level to keep in the model was used to construct parsimonious models. The associations of patient characteristics and readmission were expressed via adjusted odds ratios (ORs) with the corresponding 95% confidence intervals (CIs). All statistical analyses were performed using SAS version 9.3 (SAS Institute Inc, Cary, NC). For all tests, P < .05 was considered significant.
RESULTS
There were 350 nonemergent LEB performed during the study period. The majority of patients (61.4%) were male. Impaired ambulatory status was seen in 31.4% and 86.3% lived at home preoperatively. Patient insurance included Medicare (61.7%), Medicaid (25.4%), and private (13.0%). The majority of patients were Caucasian (46.3%) or African American (39.1%). Indications were claudication (25.6%), rest pain (17.4%), and tissue loss (57%). The distal target was the popliteal and tibial artery in 52.6% and 47.4% of cases, respectively. There were 55 patients (15.7%) who had a toe amputation and 29 (8.3%) who had a transmetatarsal amputation during Recommendation: This study suggests that surgical infections, nonsurgical wound issues, and comorbidities are causes of high readmission rates in a large safety net hospital. the same admission. The majority of bypasses used autologous vein (73.1%). Vein harvests were by continuous in incision. In-hospital complications were pulmonary complications (4.3%), urinary tract infection (3.1%), acute renal failure (2%), graft occlusion (2%), myocardial infarction (1.7%), bleeding (1.4%), surgical wound complications (1.1%), and stroke (0.9%). Mortality was 1% at 30 days, 2.6% at 90 days, and 5.2% at 1 year. There were 26 major amputations within 1 year. There were 48 ipsilateral leg interventions within 1 year. Average duration of stay was 7.1 days. The duration of stay was longer for those readmitted with 30 days (7.9 days) and for those not readmitted (6.7 days; P ¼ .04). Patients were discharged home with home services in 55% of cases and to outpatient facilities in 45%. This did not affect the 30-day readmission rate. The majority of patients were admitted through the emergency room at 30 days. Patient demographics, comorbidity, and procedural details are listed in Table I .
ARTICLE HIGHLIGHTS
The 30-day readmission rate was 30%. Reasons for readmission included surgical wound complications (41.7%), nonsurgical foot/leg wounds (10.4%), nonextremity infectious causes (7.8%), cardiac ischemia (7%), CHF (6.1%), gastrointestinal problems (6.1%), contralateral leg morbidity (5.2%), renal failure (3.5%), graft complications (2.6%), other (2.6%), altered mental status (1.7%), stroke (0.9%), diabetic complications (0.9%), and leg pain (0.9%; Table II ). In total, 55.6% of readmissions were related to the index leg.
The 90-day readmission rate for our cohort was 49.4%. Reasons for admission from 31 to 90 days included nonsurgical foot/leg wounds (19.7%), graft complications (18.4%), surgical wound complications (17.1%), cardiac ischemia (10.5%), contralateral leg morbidity (10.5%), nonextremity infectious causes (7.9%), ipsilateral leg pain (5.3%), gastrointestinal problems (3.9%), CHF (2.6%), other (2.6%), and renal failure (1.3%; Table III) . Complications involving the ipsilateral leg were the reason for readmission in 60.5% of cases.
The readmission rate at 1 year was 72.2%. Reasons for readmission from 91 days to 1 year included graft complications (22.6%), contralateral leg symptoms (15.5%), nonextremity infectious (8.3%), foot/leg wounds (6%), cardiac ischemia (6%), CHF (6%), gastrointestinal problems (4.8%), other operation (3.6%), ipsilateral leg pain (3.3%), altered mental status (2.4%), trauma (2.3%), renal failure (2.3%), surgical wound complications (1.2%), acute limb ischemia (1.2%), stroke (1.2%), diabetes (1.2%), and anemia (1.2%; Table IV ). The index leg was related to the reason for readmission in 34% of cases. We excluded 20 patients from the 1-year analysis who did not have a 1-year follow-up. We included those who died within 1 year in the 1-year readmission analysis because it is still important for resource use, and because 88% of patients who died within 1 year qualified because they were readmitted.
A tibial bypass target was associated with 30-day (OR, 1.69; 95% CI, 1.06-2.69; P ¼ .029) and 90-day (OR, 1.77; 95% CI, 1.14-2.74; P ¼ .011) readmission. Nonprivate insurance (OR, 2.31; 95% CI, 1.17-4.57; P ¼ .016) and critical limb ischemia (OR, 1.77; 95% CI, 1.14-2.74; P ¼ .035) were associated with 1-year readmission (Table V) .
DISCUSSION
Our single-center analysis found that rates of both short-and long-term readmission after LEB at a safety net hospital were higher than expected. Prior data looking at readmission after LEB have shown rates ranging from 14% to 24% within 30 days in multi-institutional databases or from nonsafety net hospitals. [10] [11] [12] [13] [14] [15] Readmission rate within 30 days was 30%, 31-90 days was 49.4%, and 1 year was 72.2%. Although the majority of the reasons for readmission at 30 and 90 days were related to the index leg, at 1 year the majority of reasons for readmission were limb unrelated. Tibial target was a predictor of readmission within 30 and 90 days. Nonprivate insurance and rest pain were independent predictors at 1 year. Index leg complications vary from the most common indication of surgical wound complications in the short term to graft infections at 1 year. However, many of the causes for readmission in the short term are related to preexisting medical comorbidities and are the majority of the reasons in the long-term follow-up. Some of these medical comorbidities could potentially have been exacerbated by the index procedure (ie, cardiac ischemia) and may therefore be related; however, other reasons, such as gastrointestinal causes of readmission, are unlikely to be linked. Therefore, some of the reasons for readmission could be considered potentially modifiable postoperative complications, whereas others are not. An operation involving a tibial bypass target was statistically associated with higher frequency of readmission at 30 and 90 days. Such LEB procedures represent more extensive operations with potentially longer incisions as well as a more severe atherosclerotic disease burden both in the affected limb and systemically. The 1-year readmission rate was associated with an initial diagnosis of critical limb ischemia and nonprivate insurance. In our study population, nonprivate insurance was the most frequently observed status, which is consistent with our hospital demographics overall. A potential implication is that 1-year readmissions, particularly for causes unrelated to the index procedure, may lead to safety net hospitals being penalized disproportionately to other hospitals, further harming these hospital systems that have relatively fewer resources. Improving resources allocation to such institutions for social support may help to decrease such readmissions. Often, patients have rest pain that may be mixed with neuropathic pain. This condition may lead to recurrent admissions for pain management, and this finding is reflected in ipsilateral leg pain as being a common cause for readmission. Patients with tissue loss often have readmissions for ongoing complications and wound care.
Two National Surgical Quality Improvement Program projects have shown 30-day readmission rates of 14.8% and 18%. 10, 13 Critical limb ischemia was associated with higher 30-day readmission rates. 10 Other factors that have been previously associated with 30-day readmission rates included poor functional status, end-stage renal disease, obesity, malnutrition, and cardiac comorbidities. 13 It was estimated that unplanned readmissions related to the original operation made up the majority (75%) of cases. The most common reasons for 30-day readmissions were wound infection (37%) and graft failure (10%). 13 The 15 Damrauer et al 11 showed that duration of stay, indication, chronic lung disease, diabetes, renal failure, postoperative CHF, and discharge status increased the risk of 30-day readmission. There are multiple limitations to this study. It is a singlecenter study and a retrospective review. Readmission information at other hospitals following LEB at our center was not documented and, therefore, our figures may underestimate the actual readmission rates. We are also unable to tell about readmissions in other healthcare systems. There are many biases and confounders to who may have received a bypass, including those that could influence our cohort. This included both patients who had aggressive endovascular treatment due to being seen as too high risk for bypass, those who were unable to be treated endovascularly, leaving those with more extensive disease in the bypass group, and those with advanced disease who could not be salvaged and, therefore, had a primary amputation. Unfortunately, it is not possible to discern these nuances in a retrospective fashion.
However, this is the first study to consider 30-day readmissions after LEB at a safety net hospital and the only study looking at readmission after 90 days and 1 year; therefore, it represents an important baseline for considering readmissions in this patient population.
CONCLUSIONS
Short-and long-term readmission rates in a safety net setting are high. The 30-day rates found in this study are higher than historically reported rates. This data sets baseline rates for 90-day and 1-year readmissions for future analyses. The majority of short-term readmissions are related to the index procedure; however, long-term readmission rates are related to systemic comorbidities. Targeted patient interventions may improve readmission rates, particularly in those with nonprivate insurance. However, other risk factors, such as tibial target, may not be modifiable and a higher readmission rate may need to be accepted in this population.
